Works by Gómez ‐ Cañas, María
Results: 11
Δ<sup>9</sup> -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB<sub>1</sub> receptors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB<sub>2</sub> receptor-dependent pathways.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prospects for cannabinoid therapies in basal ganglia disorders.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties.
- Published in:
- Archiv der Pharmazie, 2013, v. 346, n. 3, p. 171, doi. 10.1002/ardp.201200392
- By:
- Publication type:
- Article
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
- Published in:
- Scientific Reports, 2016, p. 21703, doi. 10.1038/srep21703
- By:
- Publication type:
- Article
Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01284
- By:
- Publication type:
- Article
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.
- Published in:
- Journal of NeuroImmune Pharmacology, 2012, v. 7, n. 4, p. 1002, doi. 10.1007/s11481-012-9399-3
- By:
- Publication type:
- Article
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
- Published in:
- Molecules, 2021, v. 26, n. 24, p. 7643, doi. 10.3390/molecules26247643
- By:
- Publication type:
- Article
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.
- Published in:
- Molecules, 2021, v. 26, n. 11, p. 3245, doi. 10.3390/molecules26113245
- By:
- Publication type:
- Article
Editorial: Cannabinoids as potential treatment for neurological diseases.
- Published in:
- Frontiers in Neuroscience, 2022, v. 16, p. 1, doi. 10.3389/fnins.2022.1108101
- By:
- Publication type:
- Article